<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04073420</url>
  </required_header>
  <id_info>
    <org_study_id>MDT18061SUR003</org_study_id>
    <nct_id>NCT04073420</nct_id>
  </id_info>
  <brief_title>Medtronic Cardiac Surgery PMCF Registry</brief_title>
  <official_title>Medtronic Cardiac Surgery Post Market Clinical Follow-up Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry is being conducted to support ongoing post-market surveillance activities.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 31, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2039</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2039</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Identify unique failure modes</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify trends in adverse device effects</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2700</enrollment>
  <condition>Valve Disease, Heart</condition>
  <arm_group>
    <arm_group_label>Surgical Valve Replacement and/or Repair Patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgical Heart Valve Repair Products</intervention_name>
    <description>Surgical heart valve repair products.</description>
    <arm_group_label>Surgical Valve Replacement and/or Repair Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgical Heart Valve Replacement Products</intervention_name>
    <description>Surgical heart valve replacement products.</description>
    <arm_group_label>Surgical Valve Replacement and/or Repair Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects requiring heart valve therapy replacement and/or repair.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient or legally authorized representative provides written authorization and/or
             consent per institution and geographical requirements

          2. Patient has or is intended to receive or be treated with an eligible product

          3. Patient is within enrollment window of treatment/therapy received at the time of their
             initial Registry enrollment, or meets criteria for retrospective enrollment

        Exclusion Criteria:

          1. Patient who is, or is expected to be, inaccessible for follow-up

          2. Patient prohibited from participation by local law

          3. Patient is currently enrolled in or plans to enroll in any concurrent investigational
             drug and/or device study that may confound results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julie Rapp</last_name>
    <phone>1-800-328-2518</phone>
    <email>rs.hvtpmcfregistry@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica Halverson</last_name>
    <phone>1-800-328-2518</phone>
    <email>rs.hvtpmcfregistry@medtronic.com</email>
  </overall_contact_backup>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 19, 2019</study_first_submitted>
  <study_first_submitted_qc>August 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2019</study_first_posted>
  <last_update_submitted>November 18, 2019</last_update_submitted>
  <last_update_submitted_qc>November 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

